154 related articles for article (PubMed ID: 12469186)
1. Genetic pathways of 'de novo' colorectal carcinomas with reference to fetal-type glycogen phosphorylase positive foci.
Shiomori K; Shimada S; Marutsuka T; Hatayama I; Ogawa M
Int J Oncol; 2003 Jan; 22(1):65-74. PubMed ID: 12469186
[TBL] [Abstract][Full Text] [Related]
2. Frequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomas.
Shimada S; Shiomori K; Tashima S; Tsuruta J; Ogawa M
Br J Cancer; 2001 Jun; 84(11):1497-504. PubMed ID: 11384100
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase.
Shimada S; Tashima S; Yamaguchi K; Matsuzaki H; Ogawa M
J Exp Clin Cancer Res; 1999 Mar; 18(1):111-8. PubMed ID: 10374690
[TBL] [Abstract][Full Text] [Related]
4. Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas.
Tashima S; Shimada S; Yamaguchi K; Tsuruta J; Ogawa M
Am J Gastroenterol; 2000 Jan; 95(1):255-63. PubMed ID: 10638593
[TBL] [Abstract][Full Text] [Related]
5. APC and p53 mutations in de novo colorectal adenocarcinomas.
Aoki T; Takeda S; Yanagisawa A; Kato Y; Ajioka Y; Watanabe H; Kudo S; Nakamura Y
Hum Mutat; 1994; 3(4):342-6. PubMed ID: 8081386
[TBL] [Abstract][Full Text] [Related]
6. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
7. Sequence of molecular genetic events in colorectal tumorigenesis.
Laurent-Puig P; Blons H; Cugnenc PH
Eur J Cancer Prev; 1999 Dec; 8 Suppl 1():S39-47. PubMed ID: 10772417
[TBL] [Abstract][Full Text] [Related]
8. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma.
Maesawa C; Tamura G; Suzuki Y; Ogasawara S; Sakata K; Kashiwaba M; Satodate R
J Pathol; 1995 Jul; 176(3):249-58. PubMed ID: 7674088
[TBL] [Abstract][Full Text] [Related]
9. [Genetic alterations of human colorectal cancer].
Suzuki T; Ishioka C; Gamo M; Niitani T; Shimodaira H; Kanbe M; Yamazaki T; Yusa Y; Kanamaru R
Gan To Kagaku Ryoho; 1994 Feb; 21(3):343-50. PubMed ID: 8109990
[TBL] [Abstract][Full Text] [Related]
10. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
[TBL] [Abstract][Full Text] [Related]
11. Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.
Smith G; Carey FA; Beattie J; Wilkie MJ; Lightfoot TJ; Coxhead J; Garner RC; Steele RJ; Wolf CR
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9433-8. PubMed ID: 12093899
[TBL] [Abstract][Full Text] [Related]
12. [Genome analyses for precancerous lesions in the gastrointestinal tract].
Sowa M; Nakata B
Gan To Kagaku Ryoho; 2000 Mar; 27(3):335-40. PubMed ID: 10740625
[TBL] [Abstract][Full Text] [Related]
13. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: a comparative immunohistochemical study.
Mueller J; Mueller E; Hoepner I; Jütting J; Bethke B; Stolte M; Höfler H
J Pathol; 1996 Nov; 180(3):259-65. PubMed ID: 8958802
[TBL] [Abstract][Full Text] [Related]
14. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
15. K-ras codon 12 mutation determines the polypoid growth of colorectral cancer.
Chiang JM; Chou YH; Chou TB
Cancer Res; 1998 Aug; 58(15):3289-93. PubMed ID: 9699657
[TBL] [Abstract][Full Text] [Related]
16. Telomeric repeat-length alterations in colorectal carcinoma are associated with loss of heterozygosity and point mutation in p53 gene.
Ohki S; Onda M; Fukushima T; Takita K; Suzuki S; Hoshino M; Tsuchiya A; Abe R; Takenoshita S
Int J Mol Med; 2003 Apr; 11(4):485-90. PubMed ID: 12632102
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic changes in the APC gene in sporadic colorectal carcinoma with synchronous adenoma.
Kim JC; Koo KH; Roh SA; Cho YK; Kim HC; Yu CS; Kim HJ; Kim JS; Cho MK
Int J Colorectal Dis; 2003 May; 18(3):203-9. PubMed ID: 12673484
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas.
Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S
Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399
[TBL] [Abstract][Full Text] [Related]
20. Colorectal carcinoma with special reference to growth pattern classifications: clinicopathologic characteristics and genetic changes.
Kurahashi T; Kaneko K; Makino R; Mitamura K
J Gastroenterol; 2002; 37(5):354-62. PubMed ID: 12051534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
